- This meeting has passed.
ANCO’s Hematologic Malignancies Update 2022
November 12, 2022 @ 8:00 am - 12:30 pm
The faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses.
The program takes place in San Francisco on November 12th
Registration and continental breakfast will be available at 8:00 am; presentations begin at 9 am. The program will conclude by 12:30pm.
ANCO acknowledges the support of Adaptive Biotechnologies, ADC Therapeutics, Amgen, Beigene, Incyte Corporation, Kite Pharma, Merck, Sanofi Aventis, SeaGen, and Secura Bio in making this program possible.
Attendance is limited to the first 50 health care professionals per location.
“The Case-based Multidisciplinary Management of Cancers Meeting is just one way that ANCO brings together the local oncology community. Through its roles in advocacy and education, ANCO is totally committed to the success of oncologists to help us all deliver high quality cancer care for all of Northern California. This is why I joined the ANCO Board and why every oncologist and cancer organization in Northern California should be a member of ANCO.”
Raymond Liu, MD
The Permanente Medical Group